Piero Antuono MD FAAN

Neurodegenerative, Dementia & Geriatrics

Professor of Neurology and Biophysics

Summary

Dr. Piero Antuono is a Behavioral Neurologist based in Milwaukee, WI, with subspecialties in dementia and Psychiatry. He completed his medical education at the University of Florence and pursued residencies in neurology, psychiatry and fellowship at Johns Hopkins University Since 1985, he has been a professor at the Medical College of Wisconsin. Dr. Antuono has contributed to the understanding of neurodegenerative diseases through his research on Alzheimer's disease as medical director of the Nun Study, developer of resting state fMRI in dementia and drug studies of anticholinergics and anti-amyloid compounds. He was president of the Dementia Study Group of the World Federation of Neurology and was instrumental in starting several international studies dedicated to the coordination of clinical criteria for dementia. His work has been recognized with several awards, including a Commendation from the Wisconsin Legislature and Governor. Clinically he ran a comprehensive and program for the dementias based at Froedtert Memorial Hospital and the VA Administration Hospital and was mentor to many generations of medical students and residents

Johns Hopkins UniversityResidency, Psychiatry, 1983 - 1985
Medical College of Wisconsin Affiliated HospitalsResidency, Neurology, 1980 - 1983
University of Florence Faculty of MedicineClass of 1975
Lyceum for Classical Studies, Venice ItalyNo degree, Humanities, Diploma, 1964 - 1969

WI State Medical License 1981 - 2027
MD State Medical License 1983 - 1986
American Board of Psychiatry and Neurology Neurology
United Council For Neurological SubspecialtiesBehavioral neurology and Neuropsychiatry
University of Florence,ItalyResidency in Neurology

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016
Certificate of Commendation for Alzheimer disease Wisconsin Legislature, 1988
Eureka Award Milwaukee Business Journal, 2013

PubMed

Journal Articles

Disrupted small world topology and modular organization of functional networks in late-life depression with and without amnestic mild cognitive impairment
Li W, Couglas Ward B, Liu X, Chen G, Jones JL, Antuono PG, Li SJ, Goveas JS, J Neurol Neurosurg Psychiatry, 1/28/2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Milowslavs..., N Engl J Med, 1/1/2014
Effects of the coexistence of late-life depression and mild cognitive impairment on white matter microstructure
Li W, Muftuler LT, Chen G, Ward BD, Budde MD, Jones JL, Franczak MB, Antuono PG, Li SJ, Goveas JS, J Neurol Sci, 1/1/2014

Books/Book Chapters

Frontotemporal Lobe Dementia. Current Clinical Neurology, Alzheimer’s Disease: A Physician’s Guide to Practical Management
Page 137 - 141Franczak, M., Antuono, P.G., Kerwin, D.Editors: RW Zoeller Richter.Humana Press, Inc.2004
Bioetica Della Demenza: Aspetti Pratici Per L’Operatore Sanitario
Page 19 - 56Antuono, P.G., Kerwin, D., Franczak, M.Editors: Etica e legge, Gallucci, M..Antilia Publishing2003
Decisioni Quotidiane Nell’ Alzheimer. Treviso
Page 1 - 40Gallucci, M., Antuono, P.G.Critical Medicine Publishing, RomeEdition 2nd,2002

Abstracts/Posters

The Alzheimer’s Disease Neuroimaging Initiative. The Prospectively Validated RfMRI Biomarkers for Mild Cognitive Impairment
Chen G, Shu H, Chen GY, Li W, Xu Z, Wang Z, Liu D, Ward BD, Jones J, Franczak M, Goveas J, Antuono P, Zhang Z, Li SJ, In Proc. 23th Intl. Soc. Mag. Reson. Med, Toronto, Canada, 1/5/2015
Effects of a 12-Week Exercise Intervention on Default Mode Network Connectivity in MCI Patients
Lauren R. Weiss, Theresa J. Smith, Hyuk Oh, Kristy A. Nielson, Piero Antuono, Jeri-Annette Lyons, Ryan J. Hanson, Alissa M. Butts, Nathan C. Hantke, Matthew D. Verber..., American Academy of sport medicine, Orlando, FL, 1/31/2014
resting state in midlife obese subjects at risk for Alzheimer disease
P Antuono D Gusftafson J Jones SJ Li, et al, A Assoc Intern Conf, Copenhagen, Denmark, 1/17/2014

Lectures

Other

ThirdCoast Digest. Treatments in dementia . Podcast Erin peterson manager
Antuono, P.G., FM 91.7 WMSE
Milwaukee, WI - 1/7/2011
Why a Drug Trial?
Antuono, P.G., SE Alzheimer Association Newsletter
Milwaukee, WI - 1/1/2011
The ethics of end of life
Antuono, P.G., Libera Eta
1/1/2009

The Puzzle of the MindOctober 23rd, 2020
Alzheimer's Disease Expected to Continue to Increase in Wisconsin, Report ShowsMarch 12th, 2020

In Vivo 1H Nuclear MR Study Of Hippocampus In Alzheimers DiseaseNational Center For Research Resources1999–2001
Administration Of Sb202026 In Patients With AlzheimersNational Center For Research Resources1997
Study Of Propentofylline In Patients With AlzheimersNational Center For Research Resources1996–1997
Efficacy Of Sb202026 In Patients Suffering From AlzheimersNational Center For Research Resources1996
Efficacy And Safety Of Besipiridine Hydrochloride In Patients With AlzheimersNational Center For Research Resources1996